Published in Medical Letter on the CDC and FDA, March 20th, 2000
Also, diabetics need warning that two similar medicines touted as better alternatives to Rezulin are not proven safer, the consumer group Public Citizen concluded after analyzing hundreds of pages of government documents about the drugs.
But Richard A Dickey, MD, FACP, FACE, American Association of Clinical Endocrinologists (AACE), says a press release on diabetes drugs issued by Public Citizen on March 7, 2000, "disturbs endocrinologists."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.